Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Natural Killer (NK) Cell Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Natural Killer (NK) Cell Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Natural Killer (NK) Cell Therapeutics Overall Market Size
2.1 Global Natural Killer (NK) Cell Therapeutics Market Size: 2021 VS 2028
2.2 Global Natural Killer (NK) Cell Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Natural Killer (NK) Cell Therapeutics Players in Global Market
3.2 Top Global Natural Killer (NK) Cell Therapeutics Companies Ranked by Revenue
3.3 Global Natural Killer (NK) Cell Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Natural Killer (NK) Cell Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Natural Killer (NK) Cell Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Natural Killer (NK) Cell Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Natural Killer (NK) Cell Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Natural Killer (NK) Cell Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Natural Killer (NK) Cell Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Mogamulizumab
4.1.3 Lorvotuzumab Mertansine
4.1.4 Others
4.2 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Natural Killer (NK) Cell Therapeutics Market Size, 2021 & 2028
5.1.2 Cancer
5.1.3 Cardiovascular Diseases
5.1.4 Others
5.2 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Natural Killer (NK) Cell Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Natural Killer (NK) Cell Therapeutics Revenue, 2017-2028
6.3.2 US Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.3.3 Canada Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.3.4 Mexico Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue, 2017-2028
6.4.2 Germany Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4.3 France Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4.4 U.K. Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4.5 Italy Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4.6 Russia Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4.8 Benelux Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue, 2017-2028
6.5.2 China Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.5.3 Japan Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.5.4 South Korea Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.5.6 India Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Natural Killer (NK) Cell Therapeutics Revenue, 2017-2028
6.6.2 Brazil Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.6.3 Argentina Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue, 2017-2028
6.7.2 Turkey Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.7.3 Israel Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.7.5 UAE Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Chipscreen Biosciences
7.1.1 Chipscreen Biosciences Corporate Summary
7.1.2 Chipscreen Biosciences Business Overview
7.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.1.4 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Chipscreen Biosciences Key News
7.2 Affimed NV
7.2.1 Affimed NV Corporate Summary
7.2.2 Affimed NV Business Overview
7.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.2.4 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Affimed NV Key News
7.3 Altor BioScience
7.3.1 Altor BioScience Corporate Summary
7.3.2 Altor BioScience Business Overview
7.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.3.4 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Altor BioScience Key News
7.4 Innate Pharma
7.4.1 Innate Pharma Corporate Summary
7.4.2 Innate Pharma Business Overview
7.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.4.4 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Innate Pharma Key News
7.5 Takeda
7.5.1 Takeda Corporate Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.5.4 Takeda Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Takeda Key News
7.6 Sorrento Therapeutics
7.6.1 Sorrento Therapeutics Corporate Summary
7.6.2 Sorrento Therapeutics Business Overview
7.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.6.4 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Sorrento Therapeutics Key News
7.7 NantKwest
7.7.1 NantKwest Corporate Summary
7.7.2 NantKwest Business Overview
7.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.7.4 NantKwest Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.7.5 NantKwest Key News
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporate Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.8.4 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Bristol-Myers Squibb Key News
7.9 NKT
7.9.1 NKT Corporate Summary
7.9.2 NKT Business Overview
7.9.3 NKT Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.9.4 NKT Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.9.5 NKT Key News
7.10 Henry Ford Health Services
7.10.1 Henry Ford Health Services Corporate Summary
7.10.2 Henry Ford Health Services Business Overview
7.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.10.4 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Henry Ford Health Services Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer